894
A. H. M. Elwahy, A. A. Abbas / Tetrahedron 56 (2000) 885–895
mp 233–235ЊC; MS: m/z 311 (Mϩ, 100%); 1H NMR
(DMSO) d 7.31–8.15 (m, 13H, ArHs pyridin Hs, furan
Hs) ppm. (Calcd for C21H13NO2 (311.34): C, 81.01; H,
4.21; N, 4.50. Found: C, 81.10; H, 4.40; N, 4.20).
With the use of the general procedure, 54 and 37 gave 60
(60%), mp 250–252ЊC; MS (FD): m/z 777 (Mϩ, 100%); 1H
NMR (DMSO) d 1.66 (brs, 4H, SCH2CH2), 3.11 (brs, 4H,
SCH2), 4.22 (s, 4H, CH2Ph), 5.23 (s, 4H, OCH2), 7.05–7.96
(m, 22H, ArHs), 9.12 (s, 2H, CHyN) ppm. (Calcd for
C44H40N8O2S2 (776.98): C, 68.02; H, 4.19; N, 14.42; S,
8.25. Found: C, 68.10; H, 5.30; N, 14.70; S, 8.40).
Synthesis of macrocycles 56–60
General procedure. To a solution of 37 (10 mmol) in
glacial acetic acid (30 ml) was added a solution of the
appropriate bis(4-amino-1,2,4-triazol-3-ylsulfanyl)alkanes
50–54 (10 mmol) in glacial acetic acid (30 mmol). The
reaction mixture was then heated under reflux for 2 h. The
solvent was then removed in vacuo and the remaining solid
was crystallized from acetic acid to give colorless crystals of
56–60.
Action of sodium borohydride on 57–59
General procedure. To a stirred hot (40–50ЊC) solution of
each of 57–59 (0.7 mmol) in methanol (10 ml) was added
sodium borohydride (0.4 g) over a period of 15 min. The
reaction mixture was heated under reflux for 1 h. The
solvent was then removed in vacuo and the remaining
solid was collected, washed with water and crystallized
from methanol to give colorless crystals of 61–63.
13,17-Metheno-12,18,31,32-tetrahydrobis[1,2,4]triazolo-
[4,3-f:3,4-l]dibenzo[b,l][1,18,5,6,13,14,8,11]dioxatetra-
azadithiacyclopentacosine (56). With the use of the
general procedure, 50 and 37 gave 56 (50%), mp 238–
13,17-Metheno-3,27-diphenyl-33H-5,6,12,18,24,25,31,
32-octahydrobis[1,2,4]triazolo[4,3-f:3,4-m]dibenzo-
[b,q][1,19,5,6,14,15,8,12]dioxatetraazadithiacyclohexa-
cosine (61). With the use of the general procedure, 57 gave
61 (70%), mp 182–184ЊC; 1H NMR (CDCl3) d 2.08
(quintet, J6.6 Hz, 2H, SCH2CH2), 3.09 (t, J6.4 Hz, 4H,
SCH2), 4.15 (d, J6.4 Hz, 4H, NHCH2Ar), 5.13 (s, 4H,
OCH2), 5.55 (t, J6.6 Hz, 2H, NH), 6.85–8.09 (m, 22H,
ArHs) ppm. (Calcd for C41H38N8O2S2 (738.93): C, 66.64;
H, 5.18; N, 15.16; S, 8.68. Found: C, 66.90; H, 5.20; N,
15.30; S, 8.59).
1
240ЊC; H NMR (DMSO) d 3.62 (s, 4H, SCH2), 5.32 (s,
4H, OCH2), 7.06–7.82 (m, 12H, ArHs), 8.92 (s, 2H, CH
triazol), 9.08(s, 2H, CHyN) ppm. (Calcd for
C28H24N8O2S2 (568.68): C, 59.14; H, 4.25; N, 19.70; S,
11.28. Found: C, 59.30; H, 4.10; N, 19.50; S, 11.40).
13,17-Metheno-3,27-diphenyl-33H-12,18,32,33-tetra-
hydrobis[1,2,4]triazolo[4,3-f:3,4-m]dibenzo[b,q]-
[1,19,5,6,14,15,8,12]dioxatetraazadithiacyclohexacosine
(57). With the use of the general procedure, 51 and 37 gave
57 (55%), mp 262–264ЊC; MS (FD): m/z 735 (Mϩ, 100%);
1H NMR (CDCl3) d 2.25 (quintet, J6.2 Hz, 2H,
SCH2CH2), 3.36 (t, J6.4 Hz, 4H, SCH2), 5.18 (s, 4H,
OCH2), 7.06–8.08 (m, 22H, ArHs), 9.25 (s, 2H, CHyN)
ppm. (Calcd for C41H34N8O2S2 (734.90): C, 67.01; H,
4.66; N, 15.25; S, 8.73. Found: C, 67.30; H, 4.30; N,
15.10; S, 8.90).
13,17-Metheno-3,27-dibenzyl-33H-5,6,12,18,24,25,31,32-
octahydrobis[1,2,4]triazolo[4,3-f:3,4-m]dibenzo-
[b,q][1,19,5,6,14,15,8,12]dioxatetraazadithiacyclohexa-
cosine (62). With the use of the general procedure, 58 gave
62 (75%), mp 220–222ЊC; IR (cmϪ1) 3182 (NH); 1H NMR
(CDCl3) d 2.0 (quintet, J6.4 Hz, 2H, SCH2CH2), 3.04 (t,
J6.8 Hz, 4H, SCH2), 3.84 (d, J6.2 Hz, 4H, NHCH2Ar),
3.97 (s, 4H, PhCH2), 5.09 (m, 6H, OCH2, NH), 6.93–7.43
(m, 22H, ArHs) ppm; 13C NMR (CDCl3) d 28.45
(SCH2CH2), 30.9 (CH2Ph), 31.36 (SCH2), 51.72 (CHNH),
70.21 (CH2O) 111.89, 121.48, 127.15, 127.24, 127.94,
128.88, 129.08, 130.19, 131.90 (ArCHs), 123.92, 136.14,
136.82, 150.54, 154.74, 157.49 (ArCs) ppm. (Calcd for
C43H42N8O2S2 (766.98): C, 67.34; H, 5.52; N, 14.61; S,
8.36. Found: C, 67.70; H, 5.60; N, 14.34; S, 8.18).
13,17-Metheno-3,27-dibenzyl-33H-12,18,32,33-tetra-
hydrobis[1,2,4]triazolo[4,3-f:3,4-m]dibenzo[b,q]-
[1,19,5,6,14,15,8,12]dioxatetraazadithiacyclohexacosine
(58). With the use of the general procedure, 52 and 37 gave
58 (62%), mp 240–242ЊC; MS (FD): m/z 764 (Mϩϩ1,
1
100%); H NMR (DMSO) d 1.94 (quintet J6 Hz, 2H,
SCH2CH2), 3.03 (t, J6.8 Hz, 4H, SCH2), 4.21 (s, 4H,
CH2Ph), 5.19 (s, 4H, OCH2), 7.19–7.94 (m, 22H, ArHs),
9.15 (s, 2H, CHyN) ppm. (Calcd for C43H38N8O2S2
(762.96): C, 67.69; H, 5.02; N, 14.69; S, 8.41. Found: C,
67.70; H, 4.80; N, 14.30; S, 8.60).
13,17-Metheno-3,27-diphenyl-5,6,12,18,24,25,31,32,33,
34-decahydrobis[1,2,4]triazolo[4,3-f:3,4-n]dibenzo-
[b,q][1,20,5,6,15,16,8,13]dioxatetraazadithiacyclohepta-
cosine (63). With the use of the general procedure, 59 gave
63 (65%), mp 185–187ЊC; MS: m/z 752 (Mϩ, 7%); 1H NMR
CDCl3) d 1.76 (brs, 4H, SCH2CH2), 3.11 (brs, 4H, SCH2),
4.14 (d, J6.4 Hz, 4H, NHCH2), 5.13 (s, 4H, OCH2), 5.50
(t, J6.6 Hz, 2H, NH), 6.83–8.05 (m, 22H, ArHs) ppm.
(Calcd for C42H40N8O2S2 (752.96): C, 67.00; H, 5.35; N,
14.88; S, 8.52. Found: C, 67.21; H, 5.17; N, 15.00; S, 8.29).
13,17-Metheno-3,27-diphenyl-12,18,31,32,33,34-hexa-
hydrobis[1,2,4]triazolo[4,3-f:3,4-n]dibenzo[b,q][1,20,
5,6,15,16,8,13]dioxatetraazadithiacycloheptacosine (59).
With the use of the general procedure, 53 and 37 gave 59
(55%), mp 265–267ЊC; 1H NMR (DMSO) d 1.73 (brs, 4H,
SCH2CH2), 3.14 (brs, 4H, SCH2), 5.27 (s, 4H, OCH2), 7.11–
7.97 (m, 22H, ArHs), 9.22 (s, 2H, CHyN) ppm. (Calcd for
C42H36N8O2S2 (748.93): C, 67.36; H, 4.84; N, 14.96; S,
8.56. Found: C, 62.50; H, 4.50; N, 15.10; S, 8.40).
References
3,17-Metheno-3,27-dibenzyl-12,18,31,32,33,34-hexa-
hydrobis[1,2,4]triazolo[4,3-f:3,4-n]dibenzo[b,q][1,20,
5,6,15,16,8,13]dioxatetraazadithiacycloheptacosine (60).
1. Izatt, R. M.; Bordunov, A. V.; Zhu, C. Y.; Hathaway, J. K. In
Comprehensive Supramolecular Chemistry, Gokel, G. W., Ed.;
Pergamon: New York, 1996; Vol. 1, p 3595.